LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 68.30 | 21.74 | 5061 | 6244 | 0.8105 | 0.9492 | MN20160310_N01 | H05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 68.30 | 21.74 | 555 | 6244 | 0.0889 | 0.4870 | MN20160310_N01 | I21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 68.30 | 21.74 | 5733 | 6244 | 0.9181 | 0.9792 | MN20160310_N01 | I21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 70.27 | 21.74 | 5374 | 6201 | 0.8665 | 0.9652 | MN20160310_N01 | E20 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 70.27 | 21.74 | 5401 | 6201 | 0.8709 | 0.9664 | MN20160310_N01 | E20 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 70.27 | 21.74 | 5224 | 6201 | 0.8423 | 0.9584 | MN20160310_N01 | H05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 70.27 | 21.74 | 5244 | 6201 | 0.8455 | 0.9593 | MN20160310_N01 | H05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 70.27 | 21.74 | 583 | 6201 | 0.0940 | 0.4967 | MN20160310_N01 | I21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 70.27 | 21.74 | 5992 | 6201 | 0.9662 | 0.9916 | MN20160310_N01 | I21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 72.24 | 21.74 | 5570 | 6162 | 0.9039 | 0.9754 | MN20160310_N01 | E20 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 72.24 | 21.74 | 5603 | 6162 | 0.9093 | 0.9768 | MN20160310_N01 | E20 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 72.24 | 21.74 | 5424 | 6162 | 0.8802 | 0.9689 | MN20160310_N01 | H05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 72.24 | 21.74 | 5443 | 6162 | 0.8833 | 0.9698 | MN20160310_N01 | H05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 72.24 | 21.74 | 517 | 6162 | 0.0839 | 0.4755 | MN20160310_N01 | I21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 72.24 | 21.74 | 6207 | 6162 | 1.0073 | 1.0018 | MN20160310_N01 | I21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 74.21 | 21.74 | 5819 | 6235 | 0.9332 | 0.9831 | MN20160310_N01 | E20 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 74.21 | 21.74 | 5846 | 6235 | 0.9375 | 0.9843 | MN20160310_N01 | E20 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 74.21 | 21.74 | 5553 | 6235 | 0.8905 | 0.9718 | MN20160310_N01 | H05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 74.21 | 21.74 | 5575 | 6235 | 0.8941 | 0.9728 | MN20160310_N01 | H05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 74.21 | 21.74 | 612 | 6235 | 0.0981 | 0.5050 | MN20160310_N01 | I21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 74.21 | 21.74 | 6467 | 6235 | 1.0371 | 1.0089 | MN20160310_N01 | I21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 76.18 | 21.74 | 6056 | 6114 | 0.9905 | 0.9976 | MN20160310_N01 | E20 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 76.18 | 21.74 | 6092 | 6114 | 0.9963 | 0.9991 | MN20160310_N01 | E20 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 76.18 | 21.74 | 5843 | 6114 | 0.9556 | 0.9889 | MN20160310_N01 | H05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 76.18 | 21.74 | 5865 | 6114 | 0.9592 | 0.9898 | MN20160310_N01 | H05 |